Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Ping Yen Liu, Cheng Huang Su, Feng Yu Kuo, Wen Lieng Lee, Yi Chih Wang, Wei Shiang Lin, Pao Hsien Chu, Tse Min Lu, Ping Han Lo, Cheng Han Lee, Wei Ren Lan, Chien Lung Huang, Shuji Tsukiyama, Wei Chen Yang, Li Chung Cheng, Virginia Rafael, Christian Nikolajsen, Wei Hsian Yin*

*此作品的通信作者

研究成果: Comment/debate

摘要

A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

原文English
頁(從 - 到)279-280
頁數2
期刊Cardiovascular Intervention and Therapeutics
37
發行號2
DOIs
出版狀態E-pub ahead of print - 5月 2021

指紋

深入研究「Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)」主題。共同形成了獨特的指紋。

引用此